Companies
Unicorns26
All236
Unicorns26
All Companies236
Bio23
Company
C2i GenomicsAcquired
Centivax
Cyclana Bio
Edity
Genome CompilerAcquired
Immunebridge
La Jolla Labs
Mammoth Biosciences
Mana.bio
Nanocarry
Company
Sector
First Partnered
C2i GenomicsAcquired
Bio
Series A
Centivax
Bio
Seed
Cyclana Bio
Bio
Pre-Seed
Edity
Bio
Seed
Genome CompilerAcquired
Bio, Marketplaces
GP Founder
Immunebridge
Bio
Seed
La Jolla Labs
Bio
Seed
Mammoth Biosciences
Bio
Pre-Seed
Mana.bio
Bio
Seed
Nanocarry
Bio
Seed
Company
Description
Sector
First Partnered
C2i GenomicsAcquired
Bio-platform for monitoring treatment response for solid cancers
Bio
Series A
Centivax
Universal vaccine platform
Bio
Seed
Cyclana Bio
Merging computational and tissue-level biology
Bio
Pre-Seed
Edity
Utilize T-cells machinery for in-vivo gene-editing of target cells
Bio
Seed
Genome CompilerAcquired
Market-Network for synthetic biology industry
Bio, Marketplaces
GP Founder
Immunebridge
Developing allogeneic immunotherapies for cancer
Bio
Seed
La Jolla Labs
High-throughput screening technology for RNA drug discovery
Bio
Seed
Mammoth Biosciences
The CRISPR platform for therapeutics and diagnostics
Bio
Pre-Seed
Mana.bio
Programmable drug delivery
Bio
Seed
Nanocarry
Bio transport through the blood brain barrier
Bio
Seed
See All 23 Companies
Select NFX portfolio companies included on this page are not representative of all investments in vehicles managed by NFX and there can be no assurance that the investments listed will be profitable or that other investments made in the future will have similar characteristics or results. GP Angel Investments include select prior investments made by NFX investment personnel in their personal capacities prior to joining NFX.